Teva CEO Talks Drug Pricing, Generics, Supply Shortages
Bloomberg Talks · Bloomberg
January 13, 20257m 9s
Audio is streamed directly from the publisher (podtrac.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Teva Pharmaceuticals CEO Richard Francis reflects on company performance in 2024, drug pricing, getting more drugs to market and supply shortages of the drug Adderall.
He speaks to Bloomberg's Katie Griefeld from the JPMorgan Healthcare Conference.
See omnystudio.com/listener for privacy information.